What's New
Discontinuation of oxazepam tabletsSeptember 7, 2020
Oxazepam will no longer be available in New Zealand once current stocks are exhausted. This is expected to be from mid-October 2020 (10 mg tablets) to mid-November 2020 (15 mg tablets). See the notification from PHARMAC here. Oxazepam is a short-acting benzodiazepine, with a half-life of about 6 hours. For patients currently taking oxazepam: Consider […]
Discontinuation of celiprolol tabletsAugust 27, 2020
Celiprolol tablets will no longer be available in New Zealand once current supplies are exhausted. See the notification from PHARMAC here. Celiprolol is a beta-blocker approved to treat hypertension and angina. For patients currently taking celiprolol, either: 1. Replace with an alternative beta-blocker: In most cases, we suggest the prescriber chooses the beta-blocker they are […]
Discontinuation of phenelzine tabletsMay 14, 2020
Supplies of phenelzine tablets will run out in New Zealand by the end of May 2020. See, Pharmac: Phenelzine sulfate discontinuation Guidance for withdrawal from phenelzine and switching to another antidepressant has been released in a joint statement from the New Zealand Hospital Pharmacists’ Association: Mental Health Special Interest Group and the Royal Australian & […]
Medicines supplyMay 11, 2020
The COVID-19 pandemic has affected medicine supply globally. PHARMAC has provided a summary of all medicines where there is an issue with supply. We have included this link in the ‘Useful links’ section of our site, accessed from the ‘Resources’ tab at the top. It is also in the ‘Current supply’ section of our COVID-19 […]